These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35628233)

  • 1. Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.
    Abdullah AS; Sayed IETE; El-Torgoman AMA; Kalam A; Wageh S; Kamel MA
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets.
    Abdullah AS; El Sayed IET; El-Torgoman AMA; Alghamdi NA; Ullah S; Wageh S; Kamel MA
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
    Younis N; Shaheen MA; Abdallah MH
    Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication, characterization and biological evaluation of silymarin nanoparticles against carbon tetrachloride-induced oxidative stress and genotoxicity in rats.
    Aboshanab MHA; El-Nabarawi MA; Teaima MH; El-Nekeety AA; Abdel-Aziem SH; Hassan NS; Abdel-Wahhab MA
    Int J Pharm; 2020 Sep; 587():119639. PubMed ID: 32673772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis.
    Tripathi P; Dwivedi P; Khatik R; Jaiswal AK; Dube A; Shukla P; Mishra PR
    Colloids Surf B Biointerfaces; 2015 Dec; 136():150-9. PubMed ID: 26381698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo investigation of the anti-liver fibrosis impact of Balanites aegyptiaca/ chitosan nanoparticles.
    Zein N; Yassin F; Ayoub HG; Elewa YHA; Mohamed SKA; Mahmoud MH; Elfeky M; Batiha GE; Zahran MH
    Biomed Pharmacother; 2024 Mar; 172():116193. PubMed ID: 38301419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage.
    Abdel-Moneim AM; Al-Kahtani MA; El-Kersh MA; Al-Omair MA
    PLoS One; 2015; 10(12):e0144509. PubMed ID: 26659465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antioxidant capacities of vanillin and chitosan nanoparticles against reactive oxygen species, hepatotoxicity, and genotoxicity induced by aging in male Wistar rats.
    Al-Baqami NM; Hamza RZ
    Hum Exp Toxicol; 2021 Jan; 40(1):183-202. PubMed ID: 32857622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Hepatoprotective Effect of Chokeberry Juice in Rats Treated Chronically with Carbon Tetrachloride.
    Piotrowska-Kempisty H; Nowicki M; Jodynis-Liebert J; Kurpik M; Ewertowska M; Adamska T; Oszmiański J; Kujawska M
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid.
    Telange DR; Jain SP; Pethe AM; Kharkar PS; Rarokar NR
    Int J Biol Macromol; 2021 Feb; 171():288-307. PubMed ID: 33418046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esomeprazole ameliorates CCl
    Eltahir HM; Nazmy MH
    Biomed Pharmacother; 2018 Jan; 97():1356-1365. PubMed ID: 29156525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil-CNPs) against SARS-CoV-2 (
    Loutfy SA; Abdel-Salam AI; Moatasim Y; Gomaa MR; Abdel Fattah NF; Emam MH; Ali F; ElShehaby HA; Ragab EA; Alam El-Din HM; Mostafa A; Ali MA; Kasry A
    RSC Adv; 2022 May; 12(25):15775-15786. PubMed ID: 35685696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis.
    Gharbia S; Balta C; Herman H; Rosu M; Váradi J; Bácskay I; Vecsernyés M; Gyöngyösi S; Fenyvesi F; Voicu SN; Stan MS; Cristian RE; Dinischiotu A; Hermenean A
    Front Pharmacol; 2018; 9():883. PubMed ID: 30150935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats.
    Clichici S; Olteanu D; Nagy AL; Oros A; Filip A; Mircea PA
    J Med Food; 2015 Mar; 18(3):290-8. PubMed ID: 25133972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis.
    Clichici S; Olteanu D; Filip A; Nagy AL; Oros A; Mircea PA
    J Med Food; 2016 Aug; 19(8):789-97. PubMed ID: 27441792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes.
    Kong F; Sun J; Hu Y; Huo W; Li D; Zhang W
    Assay Drug Dev Technol; 2023; 21(8):357-368. PubMed ID: 38096118
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats.
    El-Sisi AEE; Sokar SS; Shebl AM; Mohamed DZ
    Biomed Pharmacother; 2017 May; 89():1196-1206. PubMed ID: 28320086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.
    Shaker ME; Salem HA; Shiha GE; Ibrahim TM
    Fundam Clin Pharmacol; 2011 Apr; 25(2):248-57. PubMed ID: 20408881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis.
    Saber S; Goda R; El-Tanbouly GS; Ezzat D
    Int Immunopharmacol; 2018 Nov; 64():340-349. PubMed ID: 30243070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.